A controlled, randomized, open-label study to evaluate the effects of every-2-week darbepoetin alfa for anemia of cancer

Veena Charu; Chandra Belani; Ahmad Gill; Mukesh Bhatt; Ali Ben-Jacob; Dianne Tomita; Danica Katz

A controlled, randomized, open-label study to evaluate the effects of every-2-week darbepoetin alfa for anemia of cancer

Veena Charu, Chandra Belani, Ahmad Gill, Mukesh Bhatt, Ali Ben-Jacob, Dianne Tomita, Danica Katz

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	12-13
Number of pages	2
Journal	Journal of Supportive Oncology
Volume	3
Issue number	2 SUPPL. 1
State	Published - Mar 2005

All Science Journal Classification (ASJC) codes

Oncology
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{d07f705107f044ccb78cdafd4f9a6f5c,

title = "A controlled, randomized, open-label study to evaluate the effects of every-2-week darbepoetin alfa for anemia of cancer",

author = "Veena Charu and Chandra Belani and Ahmad Gill and Mukesh Bhatt and Ali Ben-Jacob and Dianne Tomita and Danica Katz",

year = "2005",

month = mar,

language = "English (US)",

volume = "3",

pages = "12--13",

journal = "Journal of Supportive Oncology",

issn = "1544-6794",

publisher = "Biolink Communications, Inc.",

number = "2 SUPPL. 1",

}

TY - JOUR

T1 - A controlled, randomized, open-label study to evaluate the effects of every-2-week darbepoetin alfa for anemia of cancer

AU - Charu, Veena

AU - Belani, Chandra

AU - Gill, Ahmad

AU - Bhatt, Mukesh

AU - Ben-Jacob, Ali

AU - Tomita, Dianne

AU - Katz, Danica

PY - 2005/3

Y1 - 2005/3

UR - http://www.scopus.com/inward/record.url?scp=15944406371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15944406371&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:15944406371

SN - 1544-6794

VL - 3

SP - 12

EP - 13

JO - Journal of Supportive Oncology

JF - Journal of Supportive Oncology

IS - 2 SUPPL. 1

ER -

A controlled, randomized, open-label study to evaluate the effects of every-2-week darbepoetin alfa for anemia of cancer

All Science Journal Classification (ASJC) codes

UN SDGs

Other files and links

Cite this